EGCG’s anticancer potential unveiled: triggering apoptosis in lung cancer cell lines through <i>in vitro</i> investigation

The research provides insights into the effects of EGCG on proliferation and migratory inhibition, as well as highlighting its potential to induce apoptosis in lung cancer cells. These results support EGCG's promise as a therapeutic agent in the treatment of lung cancer and further our understanding of the processes underlying its anticancer activities.